Neurocrine Biosciences stockNBIX
Neurocrine Biosciences trades at $159.76, 14.2% below its 52-week high (Jul 30, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +12.6% year to date, +3.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 11, 2027.
Ratings, candles, signals and the screener for NBIX — after you log in
Open the terminalFrequently asked questions about Neurocrine Biosciences
What is the Neurocrine Biosciences stock price?
At the close on Nov 5, 2026: $159.76 (−3.79% on the day). 52-week high: $186.12 on Jul 30, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Neurocrine Biosciences report earnings?
The next quarterly report is on Feb 11, 2027. Last quarter, earnings per share changed −4% year over year, revenue +41%.
Does Neurocrine Biosciences pay dividends?
No, Neurocrine Biosciences does not pay dividends.
Where does Neurocrine Biosciences trade and how to buy it?
Ticker NBIX, exchange Nasdaq, listed since 1996. You can buy it through a broker with access to US exchanges.
Should I buy Neurocrine Biosciences now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NBIX are in the terminal after you log in.